Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
AstraZeneca draws back the curtains on its leadership team, launches new podcast
Fierce Pharma
Wed, 03/8/23 - 10:02 pm
AstraZeneca
executives
podcast
AstraZeneca, Daiichi Sankyo tease new Enhertu data — but details remain under wraps
Endpoints
Mon, 03/6/23 - 11:27 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
FDA asks advisers to review Lynparza amid growing scrutiny of PARP drugs
BioPharma Dive
Sun, 03/5/23 - 03:08 pm
Merck
AstraZeneca
Lynparza
FDA
PARP inhibitors
AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates
Fierce Pharma
Thu, 03/2/23 - 11:02 pm
AstraZeneca
Merck
Lynparza
FDA
prostate cancer
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
AstraZeneca expands Canada R&D work, to add 500 jobs
Endpoints
Tue, 02/28/23 - 10:01 am
AstraZeneca
Canada
hirings
R&D
AstraZeneca pulls back the corporate curtain to highlight real people and chat complex science
Endpoints
Sun, 02/26/23 - 10:18 pm
AstraZeneca
social media
AstraZeneca strengthens its oncology R&D with in-licensing of CMG901 from China-based biotech KYM Biosciences
Medical Marketing and Media
Fri, 02/24/23 - 09:16 am
AstraZeneca
CMG901
antibody-drug conjugate
gastric cancer
KYM Biosciences
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal
Fierce Biotech
Thu, 02/23/23 - 10:00 am
AstraZeneca
Claudin18.2
KYM Biosciences
antibody-drug conjugate
pancreatic cancer
Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi
Fierce Pharma
Tue, 02/21/23 - 10:26 am
Pfizer
RSV
vaccines
GSK
AstraZeneca
Sanofi
RSVpreF
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
Mon, 02/20/23 - 12:37 pm
RSV
vaccines
GSK
Pfizer
Sanofi
Sobi
Moderna Therapeutics
AstraZeneca
JNJ
FDA
Faced with safety issues over inflammation drug, AstraZeneca spinout Aristea closes shop
Fierce Biotech
Fri, 02/10/23 - 10:43 am
Aristea Therapeutics
AstraZeneca
AstraZeneca CEO Pascal Soriot aims for 15 new drug launches by 2030
Endpoints
Thu, 02/9/23 - 06:33 pm
AstraZeneca
drug launches
Pascal Soriot
Pharma CEOs
Lower COVID sales weigh on AZ in fourth quarter
Pharmaphorum
Thu, 02/9/23 - 10:51 am
AstraZeneca
COVID-19
vaccines
earnings
AstraZeneca's Forxiga nabs expanded heart failure approval in Europe
Fierce Pharma
Tue, 02/7/23 - 06:41 pm
AstraZeneca
Europe
Forxiga
heart failure
Roche races to regulators after matching AstraZeneca's rare disease blockbuster in phase 3
Fierce Biotech
Tue, 02/7/23 - 11:04 am
Roche
PNH
AstraZeneca
crovalimab
Soliris
AstraZeneca gets personal
EP Vantage
Tue, 01/31/23 - 10:26 am
AstraZeneca
Capitainer
diagnostics
personalized medicine
AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
Endpoints
Mon, 01/30/23 - 05:58 pm
AstraZeneca
Sanofi
Novo Nordisk
340B
drug discounts
Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo
Fierce Pharma
Tue, 01/24/23 - 06:31 pm
Bristol Myers Squibb
legal
AstraZeneca
Imjudo
Yervoy
cancer
patents
AstraZeneca, Merck go multilingual for prostate cancer push
Medical Marketing and Media
Mon, 01/23/23 - 09:54 pm
AstraZeneca
Merck
pharma marketing
prostate cancer
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »